Forte Biosciences, Inc. (FBRX)

Forte Biosciences Statistics

Total Valuation

FBRX has a market cap or net worth of $230.76 million. The enterprise value is $124.61 million.

Market Cap	230.76M
Enterprise Value	124.61M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

FBRX has 17.83 million shares outstanding. The number of shares has increased by 340.93% in one year.

Current Share Class	12.43M
Shares Outstanding	17.83M
Shares Change (YoY)	+340.93%
Shares Change (QoQ)	+3.03%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	53.61%
Float	14.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.61
P/TBV Ratio	2.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.74

Current Ratio	11.74
Quick Ratio	11.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -73.46% and return on invested capital (ROIC) is -47.25%.

Return on Equity (ROE)	-73.46%
Return on Assets (ROA)	-40.79%
Return on Invested Capital (ROIC)	-47.25%
Return on Capital Employed (ROCE)	-44.30%
Revenue Per Employee	n/a
Profits Per Employee	-$3.03M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +178.88% in the last 52 weeks. The beta is 3.03, so FBRX's price volatility has been higher than the market average.

Beta (5Y)	3.03
52-Week Price Change	+178.88%
50-Day Moving Average	12.82
200-Day Moving Average	10.55
Relative Strength Index (RSI)	48.89
Average Volume (20 Days)	94,876

Short Selling Information

The latest short interest is 260,721, so 1.46% of the outstanding shares have been sold short.

Short Interest	260,721
Short Previous Month	173,022
Short % of Shares Out	1.46%
Short % of Float	1.78%
Short Ratio (days to cover)	2.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-43.68M
Pretax Income	-42.45M
Net Income	-42.45M
EBITDA	-43.64M
EBIT	-43.68M
Earnings Per Share (EPS)	-$5.46

Balance Sheet

The company has $106.14 million in cash and n/a in debt, giving a net cash position of $106.14 million or $5.95 per share.

Cash & Cash Equivalents	106.14M
Total Debt	n/a
Net Cash	106.14M
Net Cash Per Share	$5.95
Equity (Book Value)	98.61M
Book Value Per Share	8.03
Working Capital	98.45M

Cash Flow

In the last 12 months, operating cash flow was -$38.56 million and capital expenditures -$92,000, giving a free cash flow of -$38.65 million.

Operating Cash Flow	-38.56M
Capital Expenditures	-92,000
Free Cash Flow	-38.65M
FCF Per Share	-$2.17

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-340.93%
Shareholder Yield	-340.93%
Earnings Yield	-18.40%
FCF Yield	-16.75%

Analyst Forecast

The average price target for FBRX is $68.00, which is 425.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$68.00
Price Target Difference	425.50%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-14.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 28, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Aug 28, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	2